1Muirhead N, Churchill DN,Goldstein M,et al. Comparison of subcutaneous and intravenous recombinant human erythropoietin for anemia in hemodialysis patients with significant comorbid disease. Am J Nephrol, 1992,12(5) :303
3Muirhead N,Bargman J,et al. Evidence based recommendations for the clinical use of recombinat human erythropoietin. Am J Kid Dis,1995,26 (2supplel): Sl
7Albitar S,Genin R,Fen Chong M,etal. High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients.Nephrol Dial Transplant, 1998,13 (5): 1206
8Goicoechea M,Vazquez MI,etal. Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients. Nephron, 1998,78 ( 1 ): 23
